Analyze Diet
Viruses2023; 15(5); 1163; doi: 10.3390/v15051163

Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease.

Abstract: Zoonotic pathogens that are vector-transmitted have and continue to contribute to several emerging infections globally. In recent years, spillover events of such zoonotic pathogens have increased in frequency as a result of direct contact with livestock, wildlife, and urbanization, forcing animals from their natural habitats. Equines serve as reservoir hosts for vector-transmitted zoonotic viruses that are also capable of infecting humans and causing disease. From a One Health perspective, equine viruses, therefore, pose major concerns for periodic outbreaks globally. Several equine viruses have spread out of their indigenous regions, such as West Nile virus (WNV) and equine encephalitis viruses (EEVs), making them of paramount concern to public health. Viruses have evolved many mechanisms to support the establishment of productive infection and to avoid host defense mechanisms, including promoting or decreasing inflammatory responses and regulating host machinery for protein synthesis. Viral interactions with the host enzymatic machinery, specifically kinases, can support the viral infectious process and downplay innate immune mechanisms, cumulatively leading to a more severe course of the disease. In this review, we will focus on how select equine viruses interact with host kinases to support viral multiplication.
Publication Date: 2023-05-13 PubMed ID: 37243249PubMed Central: PMC10221139DOI: 10.3390/v15051163Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on how certain equine viruses interact with host kinases (enzymes within the host), impacting disease progression and host immunity. It highlights the significance of studying such interactions as they could help enhance the understanding of zoonotic diseases and globally occurring periodic outbreaks.

Overview of the Research

The paper views the significant interaction of equine viruses with the host’s own biochemical machinery, specifically their interaction with host kinases, enzymes that are fundamental to the regulation of cellular processes. The authors argue that by understanding these interactions, we can better comprehend how these zoonotic diseases are thriving and become able to devise measures to combat them.

  • The research primarily focuses on the pathogens that are zoonotic in nature and transmitted through vectors. These pathogens have been responsible for numerous emerging infections worldwide.
  • Particularly, equine viruses are emphasized as they can infect humans and cause disease, making them a major global concern. Examples include the West Nile Virus (WNV) and equine encephalitis viruses (EEVs).
  • A deeper dive is done into how these viruses interact with host kinases, which can broadly affect the host’s immune mechanisms and the severity of the disease.

Virus-Host Interactions

The authors detail how viruses, over time, have evolved mechanisms to establish a productive infection and evade host defence mechanisms.

  • Viral interactions promote or decrease inflammatory responses and regulate host machinery for protein synthesis, supporting the virus’s ability to multiply and survive.
  • Further, they interact with host kinases, enzymes that help regulate the host’s metabolic processes. This interaction can significantly iimpact the host’s innate immune mechanisms, potentially leading to a more severe course of the disease.

Significance of the Study

The paper highlights the importance of investigating virus-host kinase interactions in managing zoonotic diseases and global outbreaks.

  • An understanding of these interactions could lead to the development of more effective treatments and prevention strategies for equine-derived zoonotic diseases.
  • The increased frequency of spillover events driven by closer contact with wildlife and livestock, suggests a growing need for this field of research.

Cite This Article

APA
Anderson C, Baha H, Boghdeh N, Barrera M, Alem F, Narayanan A. (2023). Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease. Viruses, 15(5), 1163. https://doi.org/10.3390/v15051163

Publication

ISSN: 1999-4915
NlmUniqueID: 101509722
Country: Switzerland
Language: English
Volume: 15
Issue: 5
PII: 1163

Researcher Affiliations

Anderson, Carol
  • School of Systems Biology, College of Science, George Mason University, Fairfax, VA 22030, USA.
Baha, Haseebullah
  • School of Systems Biology, College of Science, George Mason University, Fairfax, VA 22030, USA.
Boghdeh, Niloufar
  • Institute of Biohealth Innovation, George Mason University, Fairfax, VA 22030, USA.
Barrera, Michael
  • School of Systems Biology, College of Science, George Mason University, Fairfax, VA 22030, USA.
Alem, Farhang
  • Institute of Biohealth Innovation, George Mason University, Fairfax, VA 22030, USA.
Narayanan, Aarthi
  • Department of Biology, College of Science, George Mason University, Fairfax, VA 22030, USA.

MeSH Terms

  • Animals
  • Humans
  • Horses
  • One Health
  • Animals, Wild
  • West Nile virus
  • Encephalomyelitis, Equine / epidemiology

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 150 references
  1. Kumar B, Manuja A, Gulati BR, Virmani N, Tripathi BN. Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health.. Open Virol J 2018;12:80-98.
    doi: 10.2174/1874357901812010080pmc: PMC6142672pubmed: 30288197google scholar: lookup
  2. Bird BH, Mazet JAK. Detection of Emerging Zoonotic Pathogens: An Integrated One Health Approach.. Annu Rev Anim Biosci 2018 Feb 15;6:121-139.
  3. Ellwanger JH, Chies JAB. Zoonotic spillover: Understanding basic aspects for better prevention.. Genet Mol Biol 2021;44(1 Suppl 1):e20200355.
  4. Hall SF, Irish JC, Groome PA, Urbach DR. Practice patterns in the management of patients with differentiated thyroid cancer in Ontario Canada 2000-2008.. J Otolaryngol Head Neck Surg 2014 Jul 24;43(1):29.
    doi: 10.1186/s40463-014-0029-3pmc: PMC4746990pubmed: 25055715google scholar: lookup
  5. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic.. Cold Spring Harb Perspect Med 2011 Sep;1(1):a006841.
    doi: 10.1101/cshperspect.a006841pmc: PMC3234451pubmed: 22229120google scholar: lookup
  6. Govender RD, Hashim MJ, Khan MA, Mustafa H, Khan G. Global Epidemiology of HIV/AIDS: A Resurgence in North America and Europe.. J Epidemiol Glob Health 2021 Sep;11(3):296-301.
    doi: 10.2991/jegh.k.210621.001pmc: PMC8435868pubmed: 34270183google scholar: lookup
  7. Hokello J, Sharma AL, Tyagi M. An Update on the HIV DNA Vaccine Strategy.. Vaccines (Basel) 2021 Jun 5;9(6).
    doi: 10.3390/vaccines9060605pmc: PMC8226902pubmed: 34198789google scholar: lookup
  8. Issel CJ, Foil LD. Equine infectious anaemia and mechanical transmission: man and the wee beasties.. Rev Sci Tech 2015 Aug;34(2):513-23.
    doi: 10.20506/rst.34.2.2376pubmed: 26601453google scholar: lookup
  9. Corrin T, Ackford R, Mascarenhas M, Greig J, Waddell LA. Eastern Equine Encephalitis Virus: A Scoping Review of the Global Evidence.. Vector Borne Zoonotic Dis 2021 May;21(5):305-320.
    doi: 10.1089/vbz.2020.2671pmc: PMC8086401pubmed: 33332203google scholar: lookup
  10. Armstrong PM, Andreadis TG. Eastern equine encephalitis virus in mosquitoes and their role as bridge vectors.. Emerg Infect Dis 2010 Dec;16(12):1869-74.
    doi: 10.3201/eid1612.100640pmc: PMC3294553pubmed: 21122215google scholar: lookup
  11. Ciota AT. Eastern Equine Encephalitis Virus Taxonomy, Genomics, and Evolution.. J Med Entomol 2022 Jan 12;59(1):14-19.
    doi: 10.1093/jme/tjab079pubmed: 34734630google scholar: lookup
  12. Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir.. Virol J 2016 Jun 3;13:87.
    doi: 10.1186/s12985-016-0544-0pmc: PMC4891877pubmed: 27255185google scholar: lookup
  13. Dzananovic E, McKenna SA, Patel TR. Viral proteins targeting host protein kinase R to evade an innate immune response: a mini review.. Biotechnol Genet Eng Rev 2018 Apr;34(1):33-59.
    doi: 10.1080/02648725.2018.1467151pubmed: 29716441google scholar: lookup
  14. Jacob T, Van den Broeke C, Favoreel HW. Viral serine/threonine protein kinases.. J Virol 2011 Feb;85(3):1158-73.
    doi: 10.1128/JVI.01369-10pmc: PMC3020496pubmed: 21084474google scholar: lookup
  15. Mudhasani R, Tran JP, Retterer C, Kota KP, Whitehouse CA, Bavari S. Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase.. PLoS Pathog 2016 Feb;12(2):e1005437.
  16. Kalveram B, Lihoradova O, Indran SV, Lokugamage N, Head JA, Ikegami T. Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.. Virology 2013 Jan 20;435(2):415-24.
    doi: 10.1016/j.virol.2012.09.031pmc: PMC3534933pubmed: 23063407google scholar: lookup
  17. Kumar R, Khandelwal N, Thachamvally R, Tripathi BN, Barua S, Kashyap SK, Maherchandani S, Kumar N. Role of MAPK/MNK1 signaling in virus replication.. Virus Res 2018 Jul 15;253:48-61.
  18. García-Cárceles J, Caballero E, Gil C, Martínez A. Kinase Inhibitors as Underexplored Antiviral Agents.. J Med Chem 2022 Jan 27;65(2):935-954.
  19. Guzmán-Terán C, Calderón-Rangel A, Rodriguez-Morales A, Mattar S. Venezuelan equine encephalitis virus: the problem is not over for tropical America.. Ann Clin Microbiol Antimicrob 2020 May 19;19(1):19.
    doi: 10.1186/s12941-020-00360-4pmc: PMC7236962pubmed: 32429942google scholar: lookup
  20. Barba M, Fairbanks EL, Daly JM. Equine viral encephalitis: prevalence, impact, and management strategies.. Vet Med (Auckl) 2019;10:99-110.
    doi: 10.2147/VMRR.S168227pmc: PMC6689664pubmed: 31497528google scholar: lookup
  21. USDA Animal and Plant Helath Inpsection Service: Equine Encephalitis (EEE/WEE/VEE) [(accessed on 23 March 2023)]; Available online: https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/animal-disease-information/equine/eee-wee-vee/equine-encephalitis.
  22. Amaya M, Keck F, Bailey C, Narayanan A. The role of the IKK complex in viral infections.. Pathog Dis 2014 Oct;72(1):32-44.
    doi: 10.1111/2049-632X.12210pmc: PMC7108545pubmed: 25082354google scholar: lookup
  23. Keck F, Ataey P, Amaya M, Bailey C, Narayanan A. Phosphorylation of Single Stranded RNA Virus Proteins and Potential for Novel Therapeutic Strategies.. Viruses 2015 Oct 12;7(10):5257-73.
    doi: 10.3390/v7102872pmc: PMC4632380pubmed: 26473910google scholar: lookup
  24. Lark T, Keck F, Narayanan A. Interactions of Alphavirus nsP3 Protein with Host Proteins.. Front Microbiol 2017;8:2652.
    doi: 10.3389/fmicb.2017.02652pmc: PMC5767282pubmed: 29375517google scholar: lookup
  25. Risner K, Ahmed A, Bakovic A, Kortchak S, Bhalla N, Narayanan A. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.. Viruses 2019 Dec 12;11(12).
    doi: 10.3390/v11121151pmc: PMC6950191pubmed: 31842327google scholar: lookup
  26. Dahal B, Lehman CW, Akhrymuk I, Bracci NR, Panny L, Barrera MD, Bhalla N, Jacobs JL, Dinman JD, Kehn-Hall K. PERK Is Critical for Alphavirus Nonstructural Protein Translation.. Viruses 2021 May 12;13(5).
    doi: 10.3390/v13050892pmc: PMC8151226pubmed: 34065980google scholar: lookup
  27. Dahal B, Lin SC, Carey BD, Jacobs JL, Dinman JD, van Hoek ML, Adams AA, Kehn-Hall K. EGR1 upregulation following Venezuelan equine encephalitis virus infection is regulated by ERK and PERK pathways contributing to cell death.. Virology 2020 Jan 2;539:121-128.
    doi: 10.1016/j.virol.2019.10.016pmc: PMC7126400pubmed: 31733451google scholar: lookup
  28. Baer A, Lundberg L, Swales D, Waybright N, Pinkham C, Dinman JD, Jacobs JL, Kehn-Hall K. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.. J Virol 2016 Jan 20;90(7):3558-72.
    doi: 10.1128/JVI.02827-15pmc: PMC4794670pubmed: 26792742google scholar: lookup
  29. Lehman CW, Kehn-Hall K, Aggarwal M, Bracci NR, Pan HC, Panny L, Lamb RA, Lin SC. Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway.. Plants (Basel) 2021 Feb 12;10(2).
    doi: 10.3390/plants10020346pmc: PMC7918260pubmed: 33673026google scholar: lookup
  30. Voss K, Amaya M, Mueller C, Roberts B, Kehn-Hall K, Bailey C, Petricoin E 3rd, Narayanan A. Inhibition of host extracellular signal-regulated kinase (ERK) activation decreases new world alphavirus multiplication in infected cells.. Virology 2014 Nov;468-470:490-503.
    doi: 10.1016/j.virol.2014.09.005pmc: PMC7127730pubmed: 25261871google scholar: lookup
  31. Balasuriya UB, Go YY, MacLachlan NJ. Equine arteritis virus.. Vet Microbiol 2013 Nov 29;167(1-2):93-122.
  32. Timoney PJ, McCollum WH. Equine viral arteritis.. Vet Clin North Am Equine Pract 1993 Aug;9(2):295-309.
  33. Nitschke M, Korte T, Tielesch C, Ter-Avetisyan G, Tünnemann G, Cardoso MC, Veit M, Herrmann A. Equine arteritis virus is delivered to an acidic compartment of host cells via clathrin-dependent endocytosis.. Virology 2008 Aug 1;377(2):248-54.
    doi: 10.1016/j.virol.2008.04.041pmc: PMC7103380pubmed: 18570963google scholar: lookup
  34. Carossino M, Dini P, Kalbfleisch TS, Loynachan AT, Canisso IF, Cook RF, Timoney PJ, Balasuriya UBR. Equine arteritis virus long-term persistence is orchestrated by CD8+ T lymphocyte transcription factors, inhibitory receptors, and the CXCL16/CXCR6 axis.. PLoS Pathog 2019 Jul;15(7):e1007950.
  35. Mottahedin A, Paidikondala M, Cholleti H, Baule C. NF-κB activation by equine arteritis virus is MyD88 dependent and promotes viral replication.. Arch Virol 2013 Mar;158(3):701-5.
    doi: 10.1007/s00705-012-1515-4pmc: PMC7086945pubmed: 23151818google scholar: lookup
  36. Go YY, Li Y, Chen Z, Han M, Yoo D, Fang Y, Balasuriya UB. Equine arteritis virus does not induce interferon production in equine endothelial cells: identification of nonstructural protein 1 as a main interferon antagonist.. Biomed Res Int 2014;2014:420658.
    doi: 10.1155/2014/420658pmc: PMC4055586pubmed: 24967365google scholar: lookup
  37. Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids.. Vet Microbiol 2013 Nov 29;167(1-2):168-80.
  38. Clark MB, Schaefer TJ. West Nile Virus.. 2023 Jan;.
    pubmed: 31334966
  39. Saiz JC. Animal and Human Vaccines against West Nile Virus.. Pathogens 2020 Dec 21;9(12).
    doi: 10.3390/pathogens9121073pmc: PMC7767344pubmed: 33371384google scholar: lookup
  40. Kobayashi S, Yoshii K, Phongphaew W, Muto M, Hirano M, Orba Y, Sawa H, Kariwa H. West Nile virus capsid protein inhibits autophagy by AMP-activated protein kinase degradation in neurological disease development.. PLoS Pathog 2020 Jan;16(1):e1008238.
  41. Scherbik SV, Brinton MA. Virus-induced Ca2+ influx extends survival of west nile virus-infected cells.. J Virol 2010 Sep;84(17):8721-31.
    doi: 10.1128/JVI.00144-10pmc: PMC2918993pubmed: 20538858google scholar: lookup
  42. Urbanowski MD, Hobman TC. The West Nile virus capsid protein blocks apoptosis through a phosphatidylinositol 3-kinase-dependent mechanism.. J Virol 2013 Jan;87(2):872-81.
    doi: 10.1128/JVI.02030-12pmc: PMC3554064pubmed: 23115297google scholar: lookup
  43. O'donnell DR, Milligan L, Stark JM. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection.. Virology 1999 Apr 25;257(1):198-207.
    doi: 10.1006/viro.1999.9650pubmed: 10208933google scholar: lookup
  44. Guo JT, Hayashi J, Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon.. J Virol 2005 Feb;79(3):1343-50.
  45. Blázquez AB, Vázquez-Calvo Á, Martín-Acebes MA, Saiz JC. Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.. Viruses 2018 Feb 23;10(2).
    doi: 10.3390/v10020091pmc: PMC5850398pubmed: 29473907google scholar: lookup
  46. Sellon DC. Equine infectious anemia.. Vet Clin North Am Equine Pract 1993 Aug;9(2):321-36.
  47. Issel CJ, Coggins L. Equine infectious anemia: current knowledge.. J Am Vet Med Assoc 1979 Apr 1;174(7):727-33.
    pubmed: 218920
  48. Hawkins JA, Adams WV, Cook L, Wilson BH, Roth EE. Role of horse fly (Tabanus fuscicostatus Hine) and stable fly (Stomoxys calcitrans L.) in transmission of equine infectious anemia to ponies in Louisiana.. Am J Vet Res 1973 Dec;34(12):1583-6.
    pubmed: 4357708
  49. Costa VMD, Cursino AE, Franco Luiz APM, Braz GF, Cavalcante PH, Souza CA, Simplício KMMG, Drumond BP, Lima MT, Teixeira BM, Kroon EG. Equine Infectious Anemia Virus (EIAV): Evidence of Circulation in Donkeys from the Brazilian Northeast Region.. J Equine Vet Sci 2022 Jan;108:103795.
    doi: 10.1016/j.jevs.2021.103795pubmed: 34800799google scholar: lookup
  50. Liu Q, Wang XF, Ma J, He XJ, Wang XJ, Zhou JH. Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome.. Viruses 2015 Jun 19;7(6):3241-60.
    doi: 10.3390/v7062769pmc: PMC4488736pubmed: 26102582google scholar: lookup
  51. Jin S, Zhang B, Weisz OA, Montelaro RC. Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway.. J Virol 2005 Dec;79(23):14489-97.
  52. Zhang B, Jin S, Jin J, Li F, Montelaro RC. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.. Proc Natl Acad Sci U S A 2005 Jul 12;102(28):9918-23.
    doi: 10.1073/pnas.0501560102pmc: PMC1174982pubmed: 15985554google scholar: lookup
  53. Shi JH, Sun SC. Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways.. Front Immunol 2018;9:1849.
    doi: 10.3389/fimmu.2018.01849pmc: PMC6094638pubmed: 30140268google scholar: lookup
  54. Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.. Mol Cell Biol 2000 Apr;20(8):2629-34.
  55. Rice AP. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.. Curr Pharm Des 2017;23(28):4098-4102.
  56. Du C, Ma J, Liu Q, Li YF, He XJ, Lin YZ, Wang XF, Meng QW, Wang X, Zhou JH. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.. Retrovirology 2015 Apr 28;12:36.
    doi: 10.1186/s12977-015-0163-7pmc: PMC4422544pubmed: 25928027google scholar: lookup
  57. Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O'Ryan M, Kang G, Desselberger U, Estes MK. Rotavirus infection.. Nat Rev Dis Primers 2017 Nov 9;3:17083.
    doi: 10.1038/nrdp.2017.83pmc: PMC5858916pubmed: 29119972google scholar: lookup
  58. Omatola CA, Olaniran AO. Rotaviruses: From Pathogenesis to Disease Control-A Critical Review.. Viruses 2022 Apr 22;14(5).
    doi: 10.3390/v14050875pmc: PMC9143449pubmed: 35632617google scholar: lookup
  59. Nemoto M, Matsumura T. Equine rotavirus infection.. J Equine Sci 2021 Mar;32(1):1-9.
    doi: 10.1294/jes.32.1pmc: PMC7984913pubmed: 33776534google scholar: lookup
  60. Sherry B. Rotavirus and reovirus modulation of the interferon response.. J Interferon Cytokine Res 2009 Sep;29(9):559-67.
    doi: 10.1089/jir.2009.0072pmc: PMC2956631pubmed: 19694545google scholar: lookup
  61. McNulty MS. Rotaviruses.. J Gen Virol 1978 Jul;40(1):1-18.
    doi: 10.1099/0022-1317-40-1-1pubmed: 80441google scholar: lookup
  62. Criglar JM, Crawford SE, Estes MK. Plasmid-based reverse genetics for probing phosphorylation-dependent viroplasm formation in rotaviruses.. Virus Res 2021 Jan 2;291:198193.
  63. Patton JT. Rotavirus replication.. Curr Top Microbiol Immunol 1994;185:107-27.
    doi: 10.1007/978-3-642-78256-5_5pubmed: 8050277google scholar: lookup
  64. Silverman RH, Weiss SR. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.. J Interferon Cytokine Res 2014 Jun;34(6):455-63.
    doi: 10.1089/jir.2014.0007pmc: PMC4046343pubmed: 24905202google scholar: lookup
  65. Bassetto M, Van Dycke J, Neyts J, Brancale A, Rocha-Pereira J. Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy.. Viruses 2019 Feb 20;11(2).
    doi: 10.3390/v11020173pmc: PMC6409847pubmed: 30791582google scholar: lookup
  66. Zhu S, Ding S, Wang P, Wei Z, Pan W, Palm NW, Yang Y, Yu H, Li HB, Wang G, Lei X, de Zoete MR, Zhao J, Zheng Y, Chen H, Zhao Y, Jurado KA, Feng N, Shan L, Kluger Y, Lu J, Abraham C, Fikrig E, Greenberg HB, Flavell RA. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells.. Nature 2017 Jun 29;546(7660):667-670.
    doi: 10.1038/nature22967pmc: PMC5787375pubmed: 28636595google scholar: lookup
  67. Eichwald C, Vascotto F, Fabbretti E, Burrone OR. Rotavirus NSP5: mapping phosphorylation sites and kinase activation and viroplasm localization domains.. J Virol 2002 Apr;76(7):3461-70.
  68. Khusro A, Aarti C, Pliego AB, Cipriano-Salazar M. Hendra Virus Infection in Horses: A Review on Emerging Mystery Paramyxovirus.. J Equine Vet Sci 2020 Aug;91:103149.
    doi: 10.1016/j.jevs.2020.103149pubmed: 32684248google scholar: lookup
  69. Middleton D. Hendra virus.. Vet Clin North Am Equine Pract 2014 Dec;30(3):579-89.
    doi: 10.1016/j.cveq.2014.08.004pmc: PMC4252762pubmed: 25281398google scholar: lookup
  70. Yuen KY, Fraser NS, Henning J, Halpin K, Gibson JS, Betzien L, Stewart AJ. Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures.. One Health 2021 Jun;12:100207.
  71. Young PL, Halpin K, Selleck PW, Field H, Gravel JL, Kelly MA, Mackenzie JS. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.. Emerg Infect Dis 1996 Jul-Sep;2(3):239-40.
    doi: 10.3201/eid0203.960315pmc: PMC2626799pubmed: 8903239google scholar: lookup
  72. Bharaj P, Wang YE, Dawes BE, Yun TE, Park A, Yen B, Basler CF, Freiberg AN, Lee B, Rajsbaum R. The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.. PLoS Pathog 2016 Sep;12(9):e1005880.
  73. Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous.. Nat Rev Microbiol 2006 Jan;4(1):23-35.
    doi: 10.1038/nrmicro1323pmc: PMC7097447pubmed: 16357858google scholar: lookup
  74. Gonzalez-Obando J, Forero JE, Zuluaga-Cabrera AM, Ruiz-Saenz J. Equine Influenza Virus: An Old Known Enemy in the Americas.. Vaccines (Basel) 2022 Oct 14;10(10).
    doi: 10.3390/vaccines10101718pmc: PMC9610386pubmed: 36298583google scholar: lookup
  75. Watson J, Daniels P, Kirkland P, Carroll A, Jeggo M. The 2007 outbreak of equine influenza in Australia: lessons learned for international trade in horses.. Rev Sci Tech 2011 Apr;30(1):87-93.
    doi: 10.20506/rst.30.1.2021pubmed: 21809755google scholar: lookup
  76. van Maanen C, Cullinane A. Equine influenza virus infections: an update.. Vet Q 2002 Jun;24(2):79-94.
    doi: 10.1080/01652176.2002.9695127pubmed: 12095083google scholar: lookup
  77. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.. Front Microbiol 2018;9:1941.
    doi: 10.3389/fmicb.2018.01941pmc: PMC6135912pubmed: 30237788google scholar: lookup
  78. Sack A, Cullinane A, Daramragchaa U, Chuluunbaatar M, Gonchigoo B, Gray GC. Equine Influenza Virus—A Neglected, Reemergent Disease Threat. Emerg Infect Dis 2019;25:1185–1191.
    doi: 10.3201/eid2506.161846google scholar: lookup
  79. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis RO. Transmission of equine influenza virus to dogs.. Science 2005 Oct 21;310(5747):482-5.
    doi: 10.1126/science.1117950pubmed: 16186182google scholar: lookup
  80. Crispe E, Finlaison DS, Hurt AC, Kirkland PD. Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak.. Aust Vet J 2011 Jul;89 Suppl 1:27-8.
  81. Daly JM, Blunden AS, Macrae S, Miller J, Bowman SJ, Kolodziejek J, Nowotny N, Smith KC. Transmission of equine influenza virus to English foxhounds.. Emerg Infect Dis 2008 Mar;14(3):461-4.
    doi: 10.3201/eid1403.070643pmc: PMC2570814pubmed: 18325262google scholar: lookup
  82. Su S, Wang L, Fu X, He S, Hong M, Zhou P, Lai A, Gray G, Li S. Equine influenza A(H3N8) virus infection in cats.. Emerg Infect Dis 2014 Dec;20(12):2096-9.
    doi: 10.3201/eid2012.140867pmc: PMC4257791pubmed: 25417790google scholar: lookup
  83. Kasel JA, Couch RB. Experimental infection in man and horses with influenza A viruses.. Bull World Health Organ 1969;41(3):447-52.
    pmc: PMC2427734pubmed: 5309454
  84. Alford RH, Kasel JA, Lehrich JR, Knight V. Human responses to experimental infection with influenza A/Equi 2 virus.. Am J Epidemiol 1967 Jul;86(1):185-92.
  85. Larson KR, Heil GL, Chambers TM, Capuano A, White SK, Gray GC. Serological evidence of equine influenza infections among persons with horse exposure, Iowa.. J Clin Virol 2015 Jun;67:78-83.
    doi: 10.1016/j.jcv.2015.04.009pubmed: 25959164google scholar: lookup
  86. Lin C, Holland RE Jr, Donofrio JC, McCoy MH, Tudor LR, Chambers TM. Caspase activation in equine influenza virus induced apoptotic cell death.. Vet Microbiol 2002 Feb 4;84(4):357-65.
    doi: 10.1016/S0378-1135(01)00468-0pubmed: 11750143google scholar: lookup
  87. Lin C, Zimmer SG, Lu Z, Holland RE Jr, Dong Q, Chambers TM. The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis.. Virology 2001 Aug 15;287(1):202-13.
    doi: 10.1006/viro.2001.1010pubmed: 11504555google scholar: lookup
  88. Lowy RJ, Dimitrov DS. Characterization of influenza virus-induced death of J774.1 macrophages.. Exp Cell Res 1997 Aug 1;234(2):249-58.
    doi: 10.1006/excr.1997.3602pubmed: 9260892google scholar: lookup
  89. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry.. Front Microbiol 2019;10:2668.
    doi: 10.3389/fmicb.2019.02668pmc: PMC6901505pubmed: 31849857google scholar: lookup
  90. DIMOCK WW, EDWARDS PR, BRUNER DW. Infections observed in equine fetuses and foals.. Cornell Vet 1947 Apr;37(2):89-99.
    pubmed: 20243963
  91. Allen G, Kydd J, Slater J, Smith K. Equid herpesvirus 1 and equid herpesvirus 4 infections. Infect Dis Livest 2004;2:829–859.
  92. Pison U, Gono E, Joka T, Obertacke U. Phospholipid lung profile in adult respiratory distress syndrome--evidence for surfactant abnormality.. Prog Clin Biol Res 1987;236A:517-23.
    pubmed: 3615448
  93. El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses.. Animals (Basel) 2021 Nov 30;11(12).
    doi: 10.3390/ani11123418pmc: PMC8697987pubmed: 34944194google scholar: lookup
  94. Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG. Equine herpesvirus-1 consensus statement.. J Vet Intern Med 2009 May-Jun;23(3):450-61.
  95. Pusterla N, David Wilson W, Madigan JE, Ferraro GL. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.. Vet J 2009 Jun;180(3):279-89.
    doi: 10.1016/j.tvjl.2008.08.004pubmed: 18805030google scholar: lookup
  96. Wilson WD. Equine herpesvirus 1 myeloencephalopathy.. Vet Clin North Am Equine Pract 1997 Apr;13(1):53-72.
    doi: 10.1016/S0749-0739(17)30255-9pubmed: 9106343google scholar: lookup
  97. Donaldson MT, Sweeney CR. Equine herpes myeloencephalopathy. Compend Contin Educ Pract Vet USA 1997;19:864–871.
  98. Studdert MJ. Virus Infections of Equines. Elsevier; Amsterdam, The Netherlands: 1996.
  99. Smith KC, Whitwell KE, Mumford JA, Gower SM, Hannant D, Tearle JP. An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1.. Equine Vet J 1993 Jan;25(1):36-40.
  100. Poyet JL, Srinivasula SM, Alnemri ES. vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma.. J Biol Chem 2001 Feb 2;276(5):3183-7.
    doi: 10.1074/jbc.C000792200pubmed: 11113112google scholar: lookup
  101. Frampton AR Jr, Stolz DB, Uchida H, Goins WF, Cohen JB, Glorioso JC. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.. J Virol 2007 Oct;81(20):10879-89.
    doi: 10.1128/JVI.00504-07pmc: PMC2045510pubmed: 17670830google scholar: lookup
  102. Cheshenko N, Liu W, Satlin LM, Herold BC. Focal adhesion kinase plays a pivotal role in herpes simplex virus entry.. J Biol Chem 2005 Sep 2;280(35):31116-25.
    doi: 10.1074/jbc.M503518200pubmed: 15994312google scholar: lookup
  103. Xie Y, Wu L, Wang M, Cheng A, Yang Q, Wu Y, Jia R, Zhu D, Zhao X, Chen S, Liu M, Zhang S, Wang Y, Xu Z, Chen Z, Zhu L, Luo Q, Liu Y, Yu Y, Zhang L, Chen X. Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets.. Front Microbiol 2019;10:941.
    doi: 10.3389/fmicb.2019.00941pmc: PMC6517553pubmed: 31134006google scholar: lookup
  104. Deng L, Fan J, Ding Y, Zhang J, Zhou B, Zhang Y, Huang B. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.. Oncotarget 2017 Jun 20;8(25):40533-40543.
    doi: 10.18632/oncotarget.17125pmc: PMC5522336pubmed: 28465492google scholar: lookup
  105. Sanford B, Holinka LG, O'Donnell V, Krug PW, Carlson J, Alfano M, Carrillo C, Wu P, Lowe A, Risatti GR, Gladue DP, Borca MV. Deletion of the thymidine kinase gene induces complete attenuation of the Georgia isolate of African swine fever virus.. Virus Res 2016 Feb 2;213:165-171.
  106. Zhao Z, Ke F, Shi Y, Zhou GZ, Gui JF, Zhang QY. Rana grylio virus thymidine kinase gene: an early gene of iridovirus encoding for a cytoplasmic protein.. Virus Genes 2009 Apr;38(2):345-52.
    doi: 10.1007/s11262-008-0318-xpubmed: 19125319google scholar: lookup
  107. Cornick J, Martens J, Martens R, Crandell R, McConnell S, Kit S. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.. Can J Vet Res 1990 Apr;54(2):260-6.
    pmc: PMC1255647pubmed: 2162730
  108. Slater JD, Gibson JS, Field HJ. Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals.. J Gen Virol 1993 May;74 ( Pt 5):819-28.
    doi: 10.1099/0022-1317-74-5-819pubmed: 8388018google scholar: lookup
  109. Schrenzel MD, Tucker TA, Donovan TA, Busch MD, Wise AG, Maes RK, Kiupel M. New hosts for equine herpesvirus 9.. Emerg Infect Dis 2008 Oct;14(10):1616-9.
    doi: 10.3201/eid1410.080703pmc: PMC2609862pubmed: 18826828google scholar: lookup
  110. Green SL. Rabies.. Vet Clin North Am Equine Pract 1997 Apr;13(1):1-11.
    doi: 10.1016/S0749-0739(17)30251-1pubmed: 9106339google scholar: lookup
  111. Gupta AK, Blondel D, Choudhary S, Banerjee AK. The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C.. J Virol 2000 Jan;74(1):91-8.
    doi: 10.1128/JVI.74.1.91-98.2000pmc: PMC111517pubmed: 10590095google scholar: lookup
  112. Fouquet B, Nikolic J, Larrous F, Bourhy H, Wirblich C, Lagaudrière-Gesbert C, Blondel D. Focal adhesion kinase is involved in rabies virus infection through its interaction with viral phosphoprotein P.. J Virol 2015 Feb;89(3):1640-51.
    doi: 10.1128/JVI.02602-14pmc: PMC4300764pubmed: 25410852google scholar: lookup
  113. Wang C, Wang J, Shuai L, Ma X, Zhang H, Liu R, Chen W, Wang X, Ge J, Wen Z, Bu Z. The Serine/Threonine Kinase AP2-Associated Kinase 1 Plays an Important Role in Rabies Virus Entry.. Viruses 2019 Dec 30;12(1).
    doi: 10.3390/v12010045pmc: PMC7019586pubmed: 31905947google scholar: lookup
  114. Sack A, Oladunni FS, Gonchigoo B, Chambers TM, Gray GC. Zoonotic Diseases from Horses: A Systematic Review.. Vector Borne Zoonotic Dis 2020 Jul;20(7):484-495.
    doi: 10.1089/vbz.2019.2541pmc: PMC7339018pubmed: 32077811google scholar: lookup
  115. Brzózka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.. J Virol 2005 Jun;79(12):7673-81.
  116. Scrima N, Le Bars R, Nevers Q, Glon D, Chevreux G, Civas A, Blondel D, Lagaudrière-Gesbert C, Gaudin Y. Rabies virus P protein binds to TBK1 and interferes with the formation of innate immunity-related liquid condensates.. Cell Rep 2023 Jan 31;42(1):111949.
    doi: 10.1016/j.celrep.2022.111949pubmed: 36640307google scholar: lookup
  117. de la Torre JC. Molecular biology of borna disease virus: prototype of a new group of animal viruses.. J Virol 1994 Dec;68(12):7669-75.
  118. Hans A, Syan S, Crosio C, Sassone-Corsi P, Brahic M, Gonzalez-Dunia D. Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells.. J Biol Chem 2001 Mar 9;276(10):7258-65.
    doi: 10.1074/jbc.M005107200pubmed: 11073944google scholar: lookup
  119. Hornig M, Briese T, Lipkin WI. Borna disease virus.. J Neurovirol 2003 Apr;9(2):259-73.
    doi: 10.1080/13550280390194064pubmed: 12707857google scholar: lookup
  120. Bode L, Dürrwald R, Ludwig H. Borna virus infections in cattle associated with fatal neurological disease.. Vet Rec 1994 Sep 17;135(12):283-4.
    doi: 10.1136/vr.135.12.283pubmed: 7817508google scholar: lookup
  121. Kao M, Hamir AN, Rupprecht CE, Fu ZF, Shankar V, Koprowski H, Dietzschold B. Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA.. Vet Rec 1993 Mar 6;132(10):241-4.
    doi: 10.1136/vr.132.10.241pubmed: 8460459google scholar: lookup
  122. Malkinson M, Weisman Y, Ashash E, Bode L, Ludwig H. Borna disease in ostriches.. Vet Rec 1993 Sep 18;133(12):304.
    doi: 10.1136/vr.133.12.304-bpubmed: 8204140google scholar: lookup
  123. Long MT, Richt JA, Grabner A, Herzog S, Garten W, Herden C. Chapter 22—Borna Disease. In: Sellon DC, Long MT, editors. Equine Infectious Diseases. 2nd ed. W.B. Saunders; St. Louis, MO, USA: 2014. pp. 226–232.e225.
  124. Zhan QL, Zhang YY, Xu MM, Hu YB, Wu XL, Yu JP, Chen X, Zhu D, Yang DY, Xie P. [Epidemiological investigation on natural infection of different canine breeds with Borna disease virus in Ili, China].. Zhonghua Liu Xing Bing Xue Za Zhi 2009 Oct;30(10):993-7.
    pubmed: 20193374
  125. Zhu D, Zeng ZL, Peng D, Chen X, Zhao LB, Zhang YY, Xu MM, Zhan QL, Yu JP, Xie P. [Epidemiological investigation on natural infection to Borna disease virus (BDV) among horses in Yili, Xinjiang].. Zhonghua Liu Xing Bing Xue Za Zhi 2008 Nov;29(11):1106-9.
    pubmed: 19173935
  126. Priestnall SL, Schöniger S, Ivens PA, Eickmann M, Brachthäuser L, Kehr K, Tupper C, Piercy RJ, Menzies-Gow NJ, Herden C. Borna disease virus infection of a horse in Great Britain.. Vet Rec 2011 Apr 9;168(14):380b.
    doi: 10.1136/vr.c6405pubmed: 21498268google scholar: lookup
  127. Wang CM, Xu P, Ge JJ, Guo ZY. [Study on molecular epidemiology of Borna disease virus in Zunyi regions of Guizhou province].. Zhonghua Liu Xing Bing Xue Za Zhi 2008 Dec;29(12):1213-6.
    pubmed: 19173966
  128. Carbone KM. Borna disease virus and human disease.. Clin Microbiol Rev 2001 Jul;14(3):513-27.
    doi: 10.1128/CMR.14.3.513-527.2001pmc: PMC88987pubmed: 11432811google scholar: lookup
  129. Rott R, Becht H. Natural and experimental Borna disease in animals.. Curr Top Microbiol Immunol 1995;190:17-30.
    doi: 10.1007/978-3-642-78618-1_2pubmed: 7789148google scholar: lookup
  130. Deschl U, Stitz L, Herzog S, Frese K, Rott R. Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease.. Acta Neuropathol 1990;81(1):41-50.
    doi: 10.1007/BF00662636pubmed: 2085093google scholar: lookup
  131. Sauder C, Staeheli P. Rat model of borna disease virus transmission: epidemiological implications.. J Virol 2003 Dec;77(23):12886-90.
  132. Richt JA, Herzog S, Haberzettl K, Rott R. Demonstration of Borna disease virus-specific RNA in secretions of naturally infected horses by the polymerase chain reaction.. Med Microbiol Immunol 1993 Dec;182(6):293-304.
    doi: 10.1007/BF00191945pubmed: 8121330google scholar: lookup
  133. Morales JA, Herzog S, Kompter C, Frese K, Rott R. Axonal transport of Borna disease virus along olfactory pathways in spontaneously and experimentally infected rats.. Med Microbiol Immunol 1988;177(2):51-68.
    doi: 10.1007/BF00189527pubmed: 2452338google scholar: lookup
  134. Richt JA, Grabner A, Herzog S. Borna disease in horses.. Vet Clin North Am Equine Pract 2000 Dec;16(3):579-95, xi.
    doi: 10.1016/S0749-0739(17)30097-4pubmed: 11219351google scholar: lookup
  135. Grabner A, Herzog S, Hafner A, Schmidt P. BDV infections of horses in Germany: Clinical and epidemiological aspects. Proceedings of the Second International Bornavirus Meeting; Freiburg, Germany. 1998.
  136. Richt JA, Pfeuffer I, Christ M, Frese K, Bechter K, Herzog S. Borna disease virus infection in animals and humans.. Emerg Infect Dis 1997 Jul-Sep;3(3):343-52.
    doi: 10.3201/eid0303.970311pmc: PMC2627631pubmed: 9284379google scholar: lookup
  137. Tizard I, Ball J, Stoica G, Payne S. The pathogenesis of bornaviral diseases in mammals.. Anim Health Res Rev 2016 Dec;17(2):92-109.
    doi: 10.1017/S1466252316000062pubmed: 27212192google scholar: lookup
  138. Ludwig H, Bode L. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology.. Rev Sci Tech 2000 Apr;19(1):259-88.
    doi: 10.20506/rst.19.1.1217pubmed: 11189720google scholar: lookup
  139. Lipkin WI, Briese T, Hornig M. Borna disease virus - fact and fantasy.. Virus Res 2011 Dec;162(1-2):162-72.
  140. Hoffmann B, Tappe D, Höper D, Herden C, Boldt A, Mawrin C, Niederstraßer O, Müller T, Jenckel M, van der Grinten E, Lutter C, Abendroth B, Teifke JP, Cadar D, Schmidt-Chanasit J, Ulrich RG, Beer M. A Variegated Squirrel Bornavirus Associated with Fatal Human Encephalitis.. N Engl J Med 2015 Jul 9;373(2):154-62.
    doi: 10.1056/NEJMoa1415627pubmed: 26154788google scholar: lookup
  141. Rubbenstroth D, Schlottau K, Schwemmle M, Rissland J, Beer M. Human bornavirus research: Back on track!. PLoS Pathog 2019 Aug;15(8):e1007873.
  142. Tappe D, Schlottau K, Cadar D, Hoffmann B, Balke L, Bewig B, Hoffmann D, Eisermann P, Fickenscher H, Krumbholz A, Laufs H, Huhndorf M, Rosenthal M, Schulz-Schaeffer W, Ismer G, Hotop SK, Brönstrup M, Ott A, Schmidt-Chanasit J, Beer M. Occupation-Associated Fatal Limbic Encephalitis Caused by Variegated Squirrel Bornavirus 1, Germany, 2013.. Emerg Infect Dis 2018 Jun;24(6):978-987.
    doi: 10.3201/eid2406.172027pmc: PMC6004865pubmed: 29774846google scholar: lookup
  143. Schlottau K, Forth L, Angstwurm K, Höper D, Zecher D, Liesche F, Hoffmann B, Kegel V, Seehofer D, Platen S, Salzberger B, Liebert UG, Niller HH, Schmidt B, Matiasek K, Riemenschneider MJ, Brochhausen C, Banas B, Renders L, Moog P, Wunderlich S, Seifert CL, Barreiros A, Rahmel A, Weiss J, Tappe D, Herden C, Schmidt-Chanasit J, Schwemmle M, Rubbenstroth D, Schlegel J, Pietsch C, Hoffmann D, Jantsch J, Beer M. Fatal Encephalitic Borna Disease Virus 1 in Solid-Organ Transplant Recipients.. N Engl J Med 2018 Oct 4;379(14):1377-1379.
    doi: 10.1056/NEJMc1803115pubmed: 30281984google scholar: lookup
  144. Korn K, Coras R, Bobinger T, Herzog SM, Lücking H, Stöhr R, Huttner HB, Hartmann A, Ensser A. Fatal Encephalitis Associated with Borna Disease Virus 1.. N Engl J Med 2018 Oct 4;379(14):1375-1377.
    doi: 10.1056/NEJMc1800724pubmed: 30281979google scholar: lookup
  145. Coras R, Korn K, Kuerten S, Huttner HB, Ensser A. Severe bornavirus-encephalitis presenting as Guillain-Barré-syndrome.. Acta Neuropathol 2019 Jun;137(6):1017-1019.
    doi: 10.1007/s00401-019-02005-zpubmed: 30953131google scholar: lookup
  146. Volmer R, Monnet C, Gonzalez-Dunia D. Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling.. PLoS Pathog 2006 Mar;2(3):e19.
  147. Schmid S, Metz P, Prat CM, Gonzalez-Dunia D, Schwemmle M. Protein kinase C-dependent phosphorylation of Borna disease virus P protein is required for efficient viral spread.. Arch Virol 2010 May;155(5):789-93.
    doi: 10.1007/s00705-010-0645-9pubmed: 20333534google scholar: lookup
  148. Schwemmle M, De B, Shi L, Banerjee A, Lipkin WI. Borna disease virus P-protein is phosphorylated by protein kinase Cepsilon and casein kinase II.. J Biol Chem 1997 Aug 29;272(35):21818-23.
    doi: 10.1074/jbc.272.35.21818pubmed: 9268312google scholar: lookup
  149. Bourteele S, Oesterle K, Pleschka S, Unterstab G, Ehrhardt C, Wolff T, Ludwig S, Planz O. Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication.. J Virol 2005 May;79(10):6043-51.
  150. Makino A, Fujino K, Parrish NF, Honda T, Tomonaga K. Borna disease virus possesses an NF-ĸB inhibitory sequence in the nucleoprotein gene.. Sci Rep 2015 Mar 3;5:8696.
    doi: 10.1038/srep08696pmc: PMC4649702pubmed: 25733193google scholar: lookup

Citations

This article has been cited 1 times.
  1. Bruno L, Nappo MA, Frontoso R, Perrotta MG, Di Lecce R, Guarnieri C, Ferrari L, Corradi A. West Nile Virus (WNV): One-Health and Eco-Health Global Risks. Vet Sci 2025 Mar 19;12(3).
    doi: 10.3390/vetsci12030288pubmed: 40266979google scholar: lookup